Q Therapeutics, Inc. — Net Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ede4f6fa-5e26-4fc2-9b56-67dac11eb408/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2014 | $-3.4M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-114403 |
| FY 2013 | $-25.1M | 2002-03-29 – 2014-03-31 | evidence 0001193125-14-201193 |
| FY 2012 | $-21.0M | 2002-03-29 – 2013-03-31 | evidence 0001193125-13-198882 |
| FY 2011 | $-18.0M | 2002-03-28 – 2012-03-31 | evidence 0001493152-12-000484 |
| FY 2010 | $-132.2k | 2005-10-27 – 2011-05-31 | evidence 0001504412-11-000118 |
| FY 2009 | $-18.2k | 2009-06-01 – 2010-05-31 | evidence 0001504412-11-000118 |
| FY 2008 | $-13.2M | 2002-03-29 – 2008-12-31 | evidence 0001387131-12-000814 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Q Therapeutics, Inc. — all facts · Revenue · Operating Income